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Liver Transplantation 
Thomas E. Stanl, M.D., Ph.D. and Charles W. Putnam, M.D. 
What I would like to do in this first paper is to give a general survey of 
liver transplantation but omit the overriding issue of liver sepsis, as this 
relates to biliary duct reconstruction. I will focus specifically on this 
problem of liver sepsis in a second report. 
Varieties of Liver Transplantation 
There are two fundamentally different kinds of hepatic transplantation 
procedures. In one , a second organ is placed in some abnormal location 
such as the paravertebral gutter, the splenic fossa or the pelvis. If ·an 
auxiliary graft is to succeed, I believe it should be revascularized according 
to the principles [ discussed in connection with the hepatotrophic factors 
in my Judd Lecture (Fig. I). Note in Figure I that the splanchnic blood 
perfuses the auxiliary liver through a mesenteric-portal anastomosis, that 
the hepatic artery is attached to the aorta and that the outflow is to the 
vena cava. 
The results with auxiliary transplantation in patients (and for that 
matter in animals) have been so discouraging that I have not done one for 
about six years. However, Dr. Joseph Fortner of New York has an 
auxiliary graft recipien t going now more than a year after the exact 
operation shown in Figure I for the indication of biliary atresia. This is a 
very important case which will certainly bear watching. 
Incidentally, some of the most interesting possibilities for auxiliary 
transplan talion are certain inborn errors of metabolism, of which I will 
men tion just two. One is the Crigler-Najjar syndrome in which the 
function of the native liver is quite normal except for the inability to 
conjugate bilirubin due to the absence of glucuronyl transferase. The 
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FIG. 1. Auxiliary liver transplantation as carried out clinically . Note that transplant 
was given a double blood supply and that the venous component was from 
nonhepatic splanchnic bed . Technique was almost identical to that developed in dogs. 
Biliary drainage should be with a ooux~n-v cholecystojejunostomy. (By permission 
of W. B. Saunders Company,1969.) 
second possibility is juvenile Gaucher's disease. Here the missing enzyme is 
Beta glucosidase. The resulting cramming of the reticuloendothelial system 
may actually lead to liver failure. With either of these disorders, an 
auxiliary liver should be curative; in the Crigler-Najjar syndrome simply by 
clearing bilirubin and in the Gaucher's patient by providing the enzyme 
which would probably reverse the hepatic lesion and cause removal of the 
deposits of glucosyl ceramide elsewhere. 
Orthotopic Transplantation 
The rest of my remarks will deal with orthotopic liver transplantation, 
that is, about liver replacement. The diseased native liver is removed and 
revascularization of the graft is performed in as anatomically normal a way 
as possible - anastomosing the portal vein and hepatic artery end-to~nd 
and reconstructing the vena cava above and below the liver. In most of our 
early cases, we have anastomosed the gallbladder to the duodenum after 
ligating the distal common duct (Fig. 2). I will be outlining the hazards of 
this approach in my second report. 
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FIG. 2. Orthotopic liver transplantation with biliary duct reconstruction by 
cholecystoduodenostomy. The cholangiogram on right was obtained at reoperation 
by inserting a Foley catheter into gallbladder. There was no evidence of obstruction. 
CBD - common bile duct; CD - cystic duct; CHD - common hepatic duct; GB -
gallbladder. (By permission of Surgery, 72:604,1972.) 
indications for Operation 
With these preliminary remarks I will now tum to the question about 
the indications for operation. At the beginning, we thought that the ideal 
reason for liver replacement would be primary hepatiC malignancies, 
including h.epatoma. Our enthusiasm was quickly dampened by the kind of 
experience which I will illustrate for you with a single case. 
In Figure 3 are chest x-rays of a 15-year-old boy. A few weeks after 
"successful" orthotopic liver transplantation for a gigantic hepatoma, 
there was already a small pulmonary metastasis. He died 143 days after 
operation with his lungs almost replaced by metastases. 
During the same interval, his new liver was similarly invaded as could 
be followed with serial scans (Fig . 4). There was evidence of metastases at 
all times after three months. He finally died of combined hepatic and 
pulmonary insufficiency. At autopsy, his lungs were a mass of tumor (Fig. 
S) . The same was true of his liver to an extent that only a tiny remnant of 
normal hepatic tissue remained (Fig . 6). 
We have had a half a dozen other so-called successful liver transplanta-
tions with subsequent widespread metastases of hepatomas and one similar 
experience with a hemangioendotheliosarcoma. Three of the patients died 
beyond one year posttransplantation of tumor spread. 
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FIG. 3. The extremely rapid development of pulmonary metastases. (A) The chest is 
clear 6 days after liver replacement for indication of hepatoma; (8) 29 days 
postoperative. Two metastases are visible in left lower lung field (arrowf); (C) 5 days 
later the tumor deposits previously seen have grown in size (horizontal Qrrowr) and a 
thud focus is now present in right upper lobe (vertical arrow); (D) 44 days. Only ten 
days have elapsed since last examination . Metastatic growths are scattered throughout 
lungs (arrowf); (E) 74 days postoperative; (F) four months after operation. Transient 
dyspnea was first noticed a few days later. Patient died of pulmonary and hepatic 
insufficiency 143 days after transplantation. (By permission of W. B. Saunders 
Company, 1969.) 
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FIG. 4. Destruction of the homograft in the same patient as Figure 3 by tumor 
recurrence. Postero-anterior and lateral liver scans were obtained with 99m · 
technetium. (A) 68 days; (8) 94 days: patient had become jaundiced; hepatomegaly 
is evident; (C) 101 days: multiple areas of poor isotope concentration are now visible; 
(D) III days: process has continued its rapid progression. By the time of death one 
month later, the homograft was almost completely replaced with cara¢oma. (By 
permission of W. B. Saunders Company, 1969.) 
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FIG. 5. Extensive pUlmonary metastaJes in same patient as in Figures 3,4 and 6. 
FIG. 6. Metastases in patient shown in Figures 3,4 and 5. 143 days after orthotopic 
liver transplantation, liver homograft has been replaced by tumor except for a very 
small residual area of hepatic parenchyma (arrows). (By permission of W. B. Saunders 
Company, 1969.) 
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It would be inaccurate to say that liver transplantation can never be 
used to cure hepatoma, as can also be illustrated by another case. In Figure 
7 is the liver of a child with biliary atresia in which was found a 2 em 
hepatoma as an incidental pathologic feature : The alpha-fetoprotein that 
was present in her serum disappeared (Fig_ 8) and has never returned. The 
child has a perfect result without evidence of tumor recurrence 4~ years 
later. Long survival after liver replacement for hepatoma has also been 
reported by Caine and Williams of Cambridge and a former fellow of ours, 
Daloze of Montreal. Nevertheless, I personally would prefer not to do 
more hepatomas at this time since the high incidence of metastases 
(exceeding 80% in our hands) has beclouded the kind of conclusions that 
must be reached in evaluating any new procedure. 
It has seemed possible that the outlook might be less gloomy if the 
malignant tumor were some kind other than a hepatoma. For example, 
some of the slow growing proximal duct cell carcinomas might be worth 
treating. This is an example, which was diagnosed with transhepatic 
cholangiography, by Alan Redeker of Los Angeles (Fig. 9). Liver 
replacement was carried out in early February with a perfect result. The 
small tumor was not seen until after its removal. 
FIG. 7. Two centimeter hepatoma (orrow,,) in the liver of a 4-year-<lld child whose 
primary diagnosis was biliary atresia. 
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FIG. 8 . Alph.a-feto protein post transplantation in child whose native liver is shown in 
Figure 7 . (By pennission of Gastroenterology, 61: 144-148, 1971.) 
FIG . 9. The diagnosis of an intrahepatic duct carcinoma by preoperative transhepatic 
cholangiography. Procedure performed by Dr. Alan Redeker of Los Angeles . 
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Table t. Criteria for Selection for Liver Transplantation 
I. Are less than 40 
2. Have a hopeless prognosis· 
3. Do not have cancer 
4. Do not have infection 
*How is this known? 
In any even (, the importan t future of hepatic transplantation is for the 
treatment of benign hepatic disease. The most common diagnoses would 
be chronic aggressive hepatitis, biliary atresia and alcoholic cirrhosis. (n all 
these situations, we would like to meet the criteria shown in Table 1. Of 
these criteria, the second one is the most difficult since the determination 
of "hopelessness" may be impossible until a few hours before death. Yet, 
if one waits this long, there will be no transplantations. 
If liver transplantation is to be prosecuted successfully, case selection 
must be carried out by different doctors in widely separated cities on a 
national basis. In doing this, the dominating role of donor availability has 
to be recognized. Another key condition is a trustworthy system of prior 
evaluation by experts of any prospective patient. Then if a suitable donor 
is found, say in Denver, a recipient who has been judged otherwise 
hopeless can be transported to Colorado. 
FIG. 10. Postmortem arteriogram of river homograft that had supported HCe for 3Y1 
yean. Note nanowed areas In lOme of the maller veuela. (By permission of the New 
En,tand Jounllll of Medicine, 289:82-84,1973.) 
. . ,
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The indication of biliary atresia for liver transplantation is perhaps the 
clearest one of all, since ¢ese children require ' a blind-end social input 
with no prospect of their getting ~tter or of growing up. With successful 
transplantation they can become quite normal. The littIegirl, whose liver 
was shown in Figure 7, is now 4~ years posttransplantation and attending 
public school in Illinois. The boy, Jimmy Grund, who was well known to 
the Minnesota faculty, was well for P~ years until his sudden death was 
precipitated by a Hemophilus septicemia. Incidentally, the arterial supply 
of his liver homograft was patent although it contained constrictions (Fig. 
10) which were apparently due to the same kind of obliterative lesions 
which are so familiar in kidney transplants. 
We have had two patients who underwent liver replacement for 
Wilson's disease, a disorder in which copper deposition in the tissues leads 
to neurologic, hepatic and other manifestations. The first patient had 
profound liver failure. The second patient recipient was treated because of 
uncontrolled neurologic manifestations despite conventional penicillamine 
therapy. Both of these patients are alive and very well after 5 and P~ 
years, respectively. After operation, they underwent a massive cupriuresis 
(Fig. 11). As the copper was being mobilized, the Kayser-Fleischer (or 
copper) rings and the neurologic manifestations regressed. Repeated 
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FIG. 11. Postoperative cupriuresis after liver replacement in a child who had Wilson's 
disease. Even after six months, note striking response to penicillamine. Child is stiU 
alive five years postoperative. (By permission of Lancet. March 13, 1971, pp. 
505-508.) 
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biopsies of these livers have shown little or no reaccumulation of hepatic 
copper. The preoperative serum ceruloplasmin of the second child was 
zero. It promptly rose to normal. 
Clinical ResuIts 
By showing you these pictures of healthy looking postoperative 
patients, I do n~t wish to give a false impression of the results that have 
been obtained. According to the April 1974 American College of Surgeons 
report on liver transplantation, about 200 patients have had liver 
replacement throughout the world. Since 1963, we have contributed 82 to 
this total, at a rate since 1967 ranging from 6% to 13% per year (Table 2). 
We have had 18 and 9 recipients, respectively, who have lived for more 
than one and two years. Thirteen recipients are still alive from eight weeks 
to almost five years postoperative. The four longest survivors are four 
years, II months; four years, 5 months; four years; and three years, 4 
months. 
There have been ten late deaths from 12 to 41 months postoperatively, 
and for the reasons listed in Table 3 . The latest mortality at three years, 
five months was Jimmy Grund, the Minnesota child whom [ mentioned 
previously. 
With only i8 one-year survivors, it is obvious that the operation is 
. presently unsafe_ The single most important factor in the high acute failure 
rate has been a multiplicity of technical misadventures of which 
complications of biliary duct reconstruction usually with lethal sepsis lead 
the list. I will be devoting all of my later talk to this topic. It is surprising 
Table 2_ Cases of Orthotopic Liver Transplantation Treated in Denver 
Lived 
Number / year 2 years Alive Now 
1963-1966 6 0 0 0 
1967 6 0 0 
1968 12 5 2 0 
1969 6 2 
1970 10 2 1 1 
1971 11 2 2 2 
1972 11 5 3 3 
1973 13 1 0 3 
1974 (To April 1) 7 0 0 3 
82 18 9 13 
I . 
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Table 3. The Present Status of 18 One-Year Survivors After Orthotopic 
Liver Transplantation. Eight ue Still Alive From 14 to 58 Months. 
The Other 10 Eventually Died From the Causes Listed Below. 
Time of Death 
OTNumber (Months) Causes of D(!Qth 
15 12 Recurrent cancer 
29 12 Serum hepatitis and liver failure 
8 IJ Recurrent cancer 
58 1 Jy, ? Chronic rejection 
? Recurrent hepatitis 
16 IJV, Rejection and liver failure 
14 14 Recurrent cancer 
54 19 Multiple liver abscesses necessitating 
retransplantation 
36 20 Systemic Nocardia infection and chronic 
aggressive hepatitis 
13 JO Rejection and liver failure following 
retransplantation 
19 41 Hemophilus septicemia and secondary liver 
and renal failure 
how uncommonly failure to control rejection has been responsible for 
death. 
One of the great unanswered questions about liver transplantation is 
whether chronic alcoholics are suitable candidates. First, cirrhotic patients 
have a predictably higher operative risk, in part due to the frequency of 
pulmonary and other infectious complications. Second , for all but those 
patien ts with clearly terminal ' esophageal variceal hemorrhage, hepatic 
coma or advanced secondary renal failure uncertainty about the natural 
course of the disease usually leads to a decision against transplantation 
until such time as the patient's condition becomes patently hopeless. Many 
then expire before a suitable liver becomes available; the few who are 
transplanted enter the operating room in a moribund state. 
In Table 4, our experience with alcoholics has been separated out. Of 
the 82 consecu tive recipients of hepatic homografts, one was treated for 
alcoholic hepatitis and nine carried the diagnosis of Laennec 's cirrhosis 
without concurrent hepatoma. Nine of the ten patients have died, from 3 
to 121 (mean 29) days posttransplantation; the only surviving recipient is 
in good condition six weeks postoperative. In contrast, 12 of the 72 
patients transplanted for nonalcoholic liver disease are still alive from a 
few weeks to nearly five years later. The mean survival of the patients in 
the nonalcoholic group who have died is more than four times that of the 
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Table 4. Alcoholic vs. Nonalcoholic Liver Disease Treated 
by Orthotopic Hepatic Transplantation 
Alcoholic Nonalcoholic To/al 
No. of patients 10 72 82 
Alive 1 * 12 13 
Dead 9 60 69 
, 
Mean survival of those who died 29 days 136 days 122 days 
*Six weeks posttransplantation 
alcoholic recipients. The causes of death among the alcoholics are 
shown in Table 5. If liver transplantation is to succeed in patients with 
alcoholic cirrhosis, potential recipients must be selected earlier , treated 
aggressively to prevent or correct infectious, pulmonary and other 
complications and transplanted before their condition has markedly 
deteriorated to the extent of coma, hepatorenal syndrome and other 
similar end points. In fact , no matter what the indication , I believe that 
operation needs to be considered earlier than we or our medical colleagues 
have been willing to recommend. 
Table 5. Duration of Survival and Cause of Death 
in Ten Alcoholic Recipients of Hepatic Homografts 
Age Sun'ival 
OTNumber (Years) (Dayr) Cause of Death 
22 33 10 Biliary obstruction 
28 39 13 Disruption of choledochoduodenostomy; 
bile peritonitis 
32 46 3 Unexplained coma 
39 47 26 Unrelieved pre~xisting coma 
40 44 32 Rejection; pneumonitis; 
petechia! hemorrhages of eNS 
62 44 121 Rejection and liver failure ; 
pUlmonary emboli 
70 40 34 Pneumonitis 
75 48 8 Rejection and liver failure 
81 47 15 Aspergillus pneumonitis with 
, dissemination 
82 37 Alive 
(6 weeks) 
I i 
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FIG. 12. The course of a teenaged boy who had liver replacement for indication of 
Wilson's disease. Acute derangements of liver function in second postoperative month 
were associated with development of Australia antigenemia. Thus, diagnosis was 
probably serum hepatitis, rather than rejection . After transplantation, the serum 
ceruloplasmin rose from zero to normal values. 
The Question of Hepatitis 
A few final thoughts may be in order. We still believe that under 
propitious circumstances, people with Australia an tigenemia need not be 
arbitrarily eliminated from candidacy. We treated a former heroin addict 
under these circumstances who lived for almost two subsequent years, 
most of it with her family, although eventually she recapitulated her 
original disease. 
I already men tioned (Table 3) that in patients who are Australia 
antigen negative, we have seen posttransplantation hepatitis . In Figure 12 
is an example. During this flare-up of hepatic malfunction, the Australia 
antigen tests had turned positive. Then, the differential diagnosis of serum 
hepatitis versus rejection may be practically impossible. 
Incidentally, I have said very little about the details of immuno-
suppressive treatmen t, since this is such a highly specialized area. We start 
out treating our patients with cyclophosphamide, steroids and ALG, later 
changing to azathioprine. 
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Summary 
I would like to summarize now by making three brief statements. 
First , the prime indication for liver replacement is non·neoplastic hepatic 
disease . Second, it has been proved that patients can be restored to good 
health with liver transplantation , as evidenced by survival for as long as 
half a decade. third , the greatest deterrent to improved results and, 
therefore, wider application is biliary duct reconstruction and hepatic 
sepsis, a combined subject which I will discuss later . 
/ 
The work wu mpported by retearch grants from the Veterans Administra~on; by 
grants AI·AM"()8898 and AM"()7772 of the National Institutes of Health; by grants 
RR"()OO51 and RR"()0069 from the General Clinical Research Centers Program o~ the 
Division of Research Resources, National Institutes of Health. 
